Tiotropium surpasses Ipratropium
...um, examined the effects of tiotropium compared to ipratropium in COPD patients over the period of one year. The ...s by 31 per cent as compared to 18 per cent in the ipratropium group. Quality of life measures increased by 52 per cent in the tiotropium group and 35 per cent in...Adult COPD or asthma could be effectively treated with Xopenex
... the Xopenex group needed only 2.0 +/- 2.6 days of ipratropium bromide treatments. Patients receiving Xopenex were found to require significantly less nebulizer therapy and less adjuvant respiratory therapy, according to the study. Xopenex is being marketed as a nebulizer at dosage strengths of 0.31 mg and 0.63...